116 related articles for article (PubMed ID: 29198659)
1. Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany.
Schrezenmeier E; Budde K; Staeck O; Lehner L; Duerr M; Khadzhynov D; Dörner T; Halleck F
Transplant Proc; 2017 Dec; 49(10):2269-2273. PubMed ID: 29198659
[TBL] [Abstract][Full Text] [Related]
2. Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy.
Chung BH; Yun JT; Ha SE; Kim JI; Moon IS; Choi BS; Park CW; Kim YS; Yang CW
Transpl Infect Dis; 2013 Dec; 15(6):559-68. PubMed ID: 24011062
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
4. Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients.
Gulleroglu K; Baskin E; Moray G; Ozdemir H; Arslan H; Haberal M
Exp Clin Transplant; 2016 Apr; 14(2):172-5. PubMed ID: 26742572
[TBL] [Abstract][Full Text] [Related]
5. Does rituximab increase the incidence of infectious complications? A narrative review.
Kelesidis T; Daikos G; Boumpas D; Tsiodras S
Int J Infect Dis; 2011 Jan; 15(1):e2-16. PubMed ID: 21074471
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.
Kamar N; Milioto O; Puissant-Lubrano B; Esposito L; Pierre MC; Mohamed AO; Lavayssière L; Cointault O; Ribes D; Cardeau I; Nogier MB; Durand D; Abbal M; Blancher A; Rostaing L
Am J Transplant; 2010 Jan; 10(1):89-98. PubMed ID: 19656128
[TBL] [Abstract][Full Text] [Related]
7. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
8. Rituximab induction therapy in highly sensitized kidney transplant recipients.
Yin H; Wan H; Hu XP; Li XB; Wang W; Liu H; Ren L; Zhang XD
Chin Med J (Engl); 2011 Jul; 124(13):1928-32. PubMed ID: 22088448
[TBL] [Abstract][Full Text] [Related]
9. Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Rommer PS; Dörner T; Freivogel K; Haas J; Kieseier BC; Kümpfel T; Paul F; Proft F; Schulze-Koops H; Schmidt E; Wiendl H; Ziemann U; Zettl UK;
J Neuroimmune Pharmacol; 2016 Mar; 11(1):1-8. PubMed ID: 26589235
[TBL] [Abstract][Full Text] [Related]
10. Single-dose rituximab for recurrent glomerulonephritis post-renal transplant.
Spinner ML; Bowman LJ; Horwedel TA; Delos Santos RB; Klein CL; Brennan DC
Am J Nephrol; 2015; 41(1):37-47. PubMed ID: 25634230
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of Infections in Living Donor Kidney Transplant Recipients: An Experience From a Tertiary Center in Nepal.
Kafle MP; Sigdel MR; Shrestha M; Shah DS
Transplant Proc; 2018 Oct; 50(8):2493-2495. PubMed ID: 30316384
[TBL] [Abstract][Full Text] [Related]
13. Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.
Habicht A; Bröker V; Blume C; Lorenzen J; Schiffer M; Richter N; Klempnauer J; Haller H; Lehner F; Schwarz A
Nephrol Dial Transplant; 2011 Dec; 26(12):4124-31. PubMed ID: 21622990
[TBL] [Abstract][Full Text] [Related]
14. Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation.
Abe T; Futamura K; Goto N; Ohara K; Ogasa T; Tomosugi T; Okada M; Hiramitsu T; Narumi S; Watarai Y
Nephrology (Carlton); 2022 Jan; 27(1):97-103. PubMed ID: 34390080
[TBL] [Abstract][Full Text] [Related]
15. Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
Aaltonen KJ; Joensuu JT; Virkki L; Sokka T; Aronen P; Relas H; Valleala H; Rantalaiho V; Pirilä L; Puolakka K; Uusitalo T; Blom M; Konttinen YT; Nordström D
J Rheumatol; 2015 Mar; 42(3):372-8. PubMed ID: 25593230
[TBL] [Abstract][Full Text] [Related]
16. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.
Grim SA; Pham T; Thielke J; Sankary H; Oberholzer J; Benedetti E; Clark NM
Clin Transplant; 2007; 21(5):628-32. PubMed ID: 17845637
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
[TBL] [Abstract][Full Text] [Related]
18. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
[TBL] [Abstract][Full Text] [Related]
19. Infection-related mortality in a large cohort of renal transplant recipients.
Linares L; Cofán F; Cervera C; Ricart MJ; Oppenheimer F; Campistol JM; Moreno A
Transplant Proc; 2007 Sep; 39(7):2225-7. PubMed ID: 17889145
[TBL] [Abstract][Full Text] [Related]
20. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
